$AURA
Aura Biosciences, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021004908 Filed on November 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.648M $2.530M $781.0K
YoY Change 167.06% 223.94%
% of Gross Profit
Research & Development $7.979M $6.365M $2.850M
YoY Change 125.2% 123.33%
% of Gross Profit
Depreciation & Amortization $230.0K $200.0K $200.0K
YoY Change 1.77% 0.0%
% of Gross Profit
Operating Expenses $11.63M $6.365M $2.850M
YoY Change 136.85% 123.33%
Operating Profit -$8.895M -$3.631M
YoY Change 144.97%
Interest Expense -$7.000K $57.00K $0.00
YoY Change -450.0%
% of Operating Profit
Other Income/Expense, Net $57.00K
YoY Change
Pretax Income -$11.63M -$8.838M -$3.631M
YoY Change 137.09% 143.4%
Income Tax
% Of Pretax Income
Net Earnings -$11.63M -$8.838M -$3.631M
YoY Change 137.09% 143.4%
Net Earnings / Revenue
Basic Earnings Per Share -$28.33
Diluted Earnings Per Share -$397.9K -$302.6K -$127.8K
COMMON SHARES
Basic Shares Outstanding 29.21M 441.4K
Diluted Shares Outstanding 441.4K

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.1M $81.83M
YoY Change
Cash & Equivalents $149.1M $81.83M $11.30M
Short-Term Investments $0.00
Other Short-Term Assets $66.00K $55.00K
YoY Change 312.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $153.7M $83.46M
YoY Change 732.86%
LONG-TERM ASSETS
Property, Plant & Equipment $5.251M $4.442M
YoY Change 46.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $125.0K $1.708M
YoY Change
Total Long-Term Assets $6.326M $7.246M
YoY Change 73.36%
TOTAL ASSETS
Total Short-Term Assets $153.7M $83.46M
Total Long-Term Assets $6.326M $7.246M
Total Assets $160.0M $90.70M
YoY Change 623.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.401M $1.736M
YoY Change 292.96%
Accrued Expenses $4.448M $3.360M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.272M $5.831M
YoY Change 173.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $442.7K $584.0K
YoY Change
Total Long-Term Liabilities $442.7K $584.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.272M $5.831M
Total Long-Term Liabilities $442.7K $584.0K
Total Liabilities $7.715M $6.415M
YoY Change 181.47%
SHAREHOLDERS EQUITY
Retained Earnings -$152.1M -$140.5M
YoY Change 30.16%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $152.3M -$131.0M -$104.0M
YoY Change
Total Liabilities & Shareholders Equity $160.0M $90.70M
YoY Change 623.99%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$11.63M -$8.838M -$3.631M
YoY Change 137.09% 143.4%
Depreciation, Depletion And Amortization $230.0K $200.0K $200.0K
YoY Change 1.77% 0.0%
Cash From Operating Activities -$12.09M -$8.690M -$6.612M
YoY Change 221.69% 31.43%
INVESTING ACTIVITIES
Capital Expenditures -$819.0K -$573.0K -$101.0K
YoY Change 520.45% 467.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$819.0K -$573.0K -$101.0K
YoY Change 520.45% 467.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.14M -1.116M 4.799M
YoY Change 1461.31% -123.25%
NET CHANGE
Cash From Operating Activities -12.09M -8.690M -6.612M
Cash From Investing Activities -819.0K -573.0K -101.0K
Cash From Financing Activities 80.14M -1.116M 4.799M
Net Change In Cash 67.24M -10.38M -1.914M
YoY Change 5304.9% 442.27%
FREE CASH FLOW
Cash From Operating Activities -$12.09M -$8.690M -$6.612M
Capital Expenditures -$819.0K -$573.0K -$101.0K
Free Cash Flow -$11.27M -$8.117M -$6.511M
YoY Change 210.81% 24.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001501796
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40971
dei Entity Registrant Name
EntityRegistrantName
AURA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0271970
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Bolton Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02140
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
500-8864
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AURA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29210549
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81829000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17393000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
19000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1609000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1043000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
83458000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18455000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
23623000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
17297000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
125000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
75000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1096000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4442000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3574000
CY2021Q3 us-gaap Deferred Costs
DeferredCosts
1583000
CY2021Q3 us-gaap Assets
Assets
90704000
CY2020Q4 us-gaap Assets
Assets
22104000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1736000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
611000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
607000
CY2021Q3 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3488000
CY2020Q4 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2050000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5831000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2661000
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
513000
CY2021Q3 aura Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
71000
CY2020Q4 aura Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
72000
CY2021Q3 us-gaap Liabilities
Liabilities
6415000
CY2020Q4 us-gaap Liabilities
Liabilities
2741000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
470183383
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
232697999
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
442717
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
442717
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
381123
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
381123
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9488000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8173000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140503000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116886000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-131015000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-108713000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90704000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22104000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6365000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2850000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17182000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14499000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2530000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
781000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6441000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2798000
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8895000
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3631000
CY2021Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-2000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
57000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.33
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-14.81
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-77.93
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-63.69
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
441448
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8895000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3631000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23623000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17297000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1000
CY2021Q3 aura Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
52000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8838000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3631000
us-gaap Net Income Loss
NetIncomeLoss
-23617000
us-gaap Net Income Loss
NetIncomeLoss
-17299000
CY2021Q3 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12506000
CY2020Q3 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-5579000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-33244000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-23101000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
376738
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
426604
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
362735
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-87406000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
177000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7512000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-94708000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
189000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6156000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-100578000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
191000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3631000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-104000000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-108713000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
265000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5927000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-114190000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1306000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
271000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-8852000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-122751000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
554000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8838000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-131015000
us-gaap Profit Loss
ProfitLoss
-23617000
us-gaap Profit Loss
ProfitLoss
-17299000
us-gaap Depreciation
Depreciation
601000
us-gaap Depreciation
Depreciation
605000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1000
us-gaap Share Based Compensation
ShareBasedCompensation
1010000
us-gaap Share Based Compensation
ShareBasedCompensation
557000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
566000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
52000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
891000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1837000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1357000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2538000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20324000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20564000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
639000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1306000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-639000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
305000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
148000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1416000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-25000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86117000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4903000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64487000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16300000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32543000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81974000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16243000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
159000
aura Initial Measurement Of Right Of Use Assets And Lease Liabilities For Operating Lease
InitialMeasurementOfRightOfUseAssetsAndLeaseLiabilitiesForOperatingLease
536000
aura Remeasurement Of Right Of Use Assets And Lease Liabilities For Lease Modification
RemeasurementOfRightOfUseAssetsAndLeaseLiabilitiesForLeaseModification
390000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
516000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81829000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11302000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20000
us-gaap Net Income Loss
NetIncomeLoss
-17300000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
82000000.0
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140500000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4866000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
125000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
75000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81974000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16243000
us-gaap Net Income Loss
NetIncomeLoss
-23600000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
735000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
277000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1600000
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0
CY2021Q3 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3488000
CY2020Q4 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2050000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6975000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5926000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2533000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2352000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4442000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3574000
CY2021Q3 us-gaap Depreciation
Depreciation
200000
CY2020Q3 us-gaap Depreciation
Depreciation
200000
us-gaap Depreciation
Depreciation
600000
us-gaap Depreciation
Depreciation
600000
CY2021Q3 us-gaap Prepaid Insurance
PrepaidInsurance
80000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
51000
CY2021Q3 aura Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
1474000
CY2020Q4 aura Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
976000
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
55000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1609000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1043000
CY2021Q3 aura Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
1184000
CY2020Q4 aura Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
750000
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1569000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1023000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
442717
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
442717
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
381123
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
381123
aura Preferred Stock Liquidation Rights Description
PreferredStockLiquidationRightsDescription
In the event of a Deemed Liquidation Event, as defined in the Company’s amended and restated Certificate of Incorporation, the assets of the Company will be distributed first to the holders of the Series E. The holders of the Series E will receive, in preference to all other stockholders, an amount equal to the sum of the Series E original issue price (equal to the cash price paid per share of $0.783900), plus unpaid dividends on such shares. Next, the holders of the Series D will receive, in preference to all other stockholders other than the Series E, an amount equal to the sum of the Series D original issue price, plus unpaid dividends on such shares. Next, the holders of the Series C will receive, in preference to all stockholders other than the Series E and D holders, an amount equal to the sum of the Series C original issue price plus unpaid dividends on such shares. Next, the holders of the Series B will receive, in preference to the holders of the Series A, Series A-1, Series A-2 and common stock, an amount equal to the sum of the Series B original issue price plus unpaid dividends on such shares. Next, the holders of the Series A, Series A-1, and Series A-2 will receive, in preference to the holders of common stock, an amount equal to the greater of their applicable liquidation preference or what they would have received had their shares converted into common stock. If the proceeds available are not sufficient to satisfy the full liquidation preference, the entire proceeds are to be distributed pro-rata among the Series E holders in proportion to the full preferential amount the Series E holders are entitled to receive.
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
one-for-one basis
CY2021Q3 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
1
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
470183383
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
232697999
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10000.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20000.00
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0100
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0033
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0106
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0058
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y21D
us-gaap Lease Cost
LeaseCost
614000
CY2021Q1 aura Operating Lease Termination Date
OperatingLeaseTerminationDate
2023-07-31
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M1D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y10D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7336
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7371
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7421
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7416
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000
us-gaap Operating Lease Payments
OperatingLeasePayments
367000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M29D
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0794
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
554000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
191000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1010000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
557000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M9D
CY2021Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
4516
CY2021Q1 aura Lease Commencement Date
LeaseCommencementDate
2021-05-01
CY2021Q1 aura Additional Area Of Rented Space
AdditionalAreaOfRentedSpace
1000
CY2021Q1 aura Additional Leased Space Commencement Date
AdditionalLeasedSpaceCommencementDate
2021-06-15
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-14.81
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-77.93
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-63.69
CY2021Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P12M
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
11000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
154000
us-gaap Operating Lease Cost
OperatingLeaseCost
370000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
90000
us-gaap Variable Lease Cost
VariableLeaseCost
233000
CY2021Q3 us-gaap Lease Cost
LeaseCost
244000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0351
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25728196
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14686345
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25728196
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14686345
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
153000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
625000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
377000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1155000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
35000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1120000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
607000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
513000
aura Licensed Patents And Patent Applications
LicensedPatentsAndPatentApplications
30000.00
CY2019Q3 aura Upfront Payment
UpfrontPayment
100000
CY2019Q3 aura Aggregate Milestones Payment
AggregateMilestonesPayment
21000000.0
CY2019Q3 aura Royalties On Net Sales
RoyaltiesOnNetSales
0.20
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8838000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3631000
us-gaap Net Income Loss
NetIncomeLoss
-23617000
us-gaap Net Income Loss
NetIncomeLoss
-17299000
CY2021Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3668000
CY2020Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1948000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
9627000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
5802000
CY2021Q3 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12506000
CY2020Q3 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-5579000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-33244000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-23101000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
441448
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
376738
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
426604
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
362735
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.33
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0

Files In Submission

Name View Source Status
0000950170-21-004908-index-headers.html Edgar Link pending
0000950170-21-004908-index.html Edgar Link pending
0000950170-21-004908.txt Edgar Link pending
0000950170-21-004908-xbrl.zip Edgar Link pending
aura-20210930.htm Edgar Link pending
aura-20210930.xsd Edgar Link pending
aura-20210930_cal.xml Edgar Link unprocessable
aura-20210930_def.xml Edgar Link unprocessable
aura-20210930_htm.xml Edgar Link completed
aura-20210930_lab.xml Edgar Link unprocessable
aura-20210930_pre.xml Edgar Link unprocessable
aura-ex31_1.htm Edgar Link pending
aura-ex31_2.htm Edgar Link pending
aura-ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending